Search

everythinglearnresearchcommunity

for

Search:↓

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Tangent screens help detect visual field defects from vigabatrin.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Tofacitinib may effectively treat folliculitis decalvans.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

New isatin-gallate hybrids show promise as antioxidants, cancer treatments, and coronavirus inhibitors.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Imatinib can cause hair loss due to lichen planopilaris.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Tofacitinib effectively regrew scalp hair in an 11-year-old girl with alopecia areata.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Caribine from traditional Chinese medicine may help treat hair loss.

Promising cancer treatments were found, but the manufacturer closed.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Nilotinib can cause generalized keratosis pilaris.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.